Borderline personality disorder is a serious mental illness characterized by affective instability, disturbances in self-image, and difficulties with interpersonal relationships. Psychotropic medications are not considered a first-line treatment for this condition; however, they may be used to treat comorbid mental disorders or symptoms. Psychotherapeutic approaches, in particular dialectical behavioral therapy (DBT), have shown promise in addressing this condition. DBT includes individual and group visits using cognitive and behavioral strategies to build patients’ ability to tolerate distress, reduce reactivity, and learn and practice new social skills. DBT has been demonstrated to address self-destructive behaviors and reduce suicide attempts among individuals with borderline personality disorder and a history of suicidal behaviors.
For more information on borderline personality disorder, visit: https://www.nimh.nih.gov/health/topics/borderline-personality-disorder/index.shtml
Emotions Matter released an advocacy resource on “Utilizing Single Case Agreements To Access Treatment For Borderline Personality Disorder (BPD)”. You can visit this resource at: https://static1.squarespace.com/static/56aab18d4bf11837b0fa5fe9/t/5bd897ee4785d3f0b14b31c3/1540921334602/SCA+Final.pdf